Buy Opdyta Nivolumab 40mg Injection Online from GlobMedIndia – Trusted Anti-Cancer Medicine Exporter USA, UK, UAE Australia, Europe, United Kingdom, United States, Cambridge, London, Morocco, Indonesia, Chile, Peru, Ethiopia, Romania, China, Japan, Russia, Ukraine, Dubai, United Arab Emirates, South Korea, Africa, Thailand, Vietnam, Middle East, and Southeast Asian countries. - GLOB MED INDIA PHARMA EXPORTER,South Africa

Opdyta Nivolumab 40mg Injection

Introduction

Opdyta Nivolumab 40mg Injection is an advanced anti-cancer medication used in immunotherapy. It contains Nivolumab, a monoclonal antibody that helps the body’s immune system recognize and fight cancer cells more effectively. It belongs to a class of drugs known as immune checkpoint inhibitors, specifically targeting the PD-1 (Programmed Death-1) pathway.

This injection is widely used in the treatment of multiple types of cancers and is administered under the supervision of a qualified oncologist.

📞 Contact Details to Place Order

💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
🌐 Website: https://globmedindia.com

Composition and Content

Active Ingredient: Nivolumab
Strength: 40 mg per vial
Form: Sterile solution for intravenous infusion
Drug Class: Immune checkpoint inhibitor (PD-1 inhibitor)

Nivolumab works by blocking the PD-1 protein on T-cells, enhancing the immune system’s ability to attack cancer cells.

How to Use

Administered as an intravenous (IV) infusion
Given in a hospital or clinical setting by a trained healthcare professional
Infusion usually takes 30 to 60 minutes
Do not self-administer

Dosage

Dosage depends on:
- Body weight
- Type of cancer
- Patient’s overall health condition
Common regimens:
- 240 mg every 2 weeks OR
- 480 mg every 4 weeks (depending on protocol)

Note: The 40mg vial is typically used as part of dose calculation.

Uses

Opdyta Nivolumab is used to treat various cancers, including:

Non-Small Cell Lung Cancer (NSCLC)
Melanoma (skin cancer)
Renal Cell Carcinoma (kidney cancer)
Head and Neck Cancer
Hodgkin Lymphoma
Urothelial Carcinoma (bladder cancer)
Colorectal cancer (MSI-H/dMMR types)
Liver cancer (Hepatocellular carcinoma)

Treatment Mechanism

Blocks PD-1 receptor on immune cells
Prevents cancer cells from escaping immune detection
Enhances T-cell response against tumors

Advantages

Targeted immunotherapy with fewer side effects than chemotherapy
Improves survival rates in several cancers
Long-lasting immune response
Can be used alone or in combination with other therapies

Storage Conditions

Store in a refrigerator at 2°C to 8°C
Do not freeze
Protect from light
Keep in original packaging
Use immediately after dilution (as per medical guidelines)

Alternative Indian Brands for Nivolumab Injection

Some commonly available alternatives include:

Nivolumab Injection by Biocon
Nivolumab by Dr. Reddy’s Laboratories
Nivolumab by Hetero Healthcare
Opdivo (innovator brand by Bristol Myers Squibb)